[go: up one dir, main page]

HK1061651A - Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen - Google Patents

Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen Download PDF

Info

Publication number
HK1061651A
HK1061651A HK04104667.0A HK04104667A HK1061651A HK 1061651 A HK1061651 A HK 1061651A HK 04104667 A HK04104667 A HK 04104667A HK 1061651 A HK1061651 A HK 1061651A
Authority
HK
Hong Kong
Prior art keywords
antigen
hsv
hpv
hiv
multivalent vaccine
Prior art date
Application number
HK04104667.0A
Other languages
Chinese (zh)
Inventor
Debrus Serge
L. Mathy Nathalie
Voss Gerald
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of HK1061651A publication Critical patent/HK1061651A/en

Links

HK04104667.0A 2001-04-27 2002-04-25 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen HK1061651A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0110431.4 2001-04-27

Publications (1)

Publication Number Publication Date
HK1061651A true HK1061651A (en) 2004-09-30

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
AU2002336760A1 (en) Mutable vaccines
AU2001252458A1 (en) Molecular antigen arrays and vaccines
AU2002254558A1 (en) Novel vaccine
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
WO2002087614A3 (en) Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
AU2002361559A1 (en) Anticancer vaccine and diganostic methods and reagents
AU2002307971A1 (en) Vaccine against the nile fever virus
AU2002306736A1 (en) A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same
AU2002305028A1 (en) West nile virus epitopes and uses thereof
AU2001269640A1 (en) Vaccine against the influenza virus and method for producing said virus vaccine
AU2002228347A1 (en) Malaria plasmodium antigen polypeptide SE36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen
AU2003267361A1 (en) Orthopoxvirus antigens and use thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2002236065A1 (en) Papillomavirus vaccines
HK1061651A (en) Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AU4957800A (en) Vaccine against isa virus
AU2002325783A1 (en) Vaccine formulation potentiated by the combination of a DNA and an antigen
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2001270209A1 (en) Hiv-1 vaccines and screening methods therefor
AU2002340850A1 (en) Antigen mimotopes and vaccine against cancers
AU2002314274A1 (en) Vaccination against the feline immunodeficiency virus
AU2001266534A1 (en) Papillomavirus vaccine
AU2002223398A1 (en) A vaccine for influenza virus and its preparation